National Asset Management, Inc. Biomarin Pharmaceutical Inc Transaction History

National Asset Management, Inc.

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 17, 2023	SELL	$87.74 - $117.27 $24,654 - $32,952	-281 Reduced 10.72%	2,341 $227,000
Q4 2022 Feb 21, 2023	BUY	$80.93 - $108.63 $212,198 - $284,827	2,622 New	2,622 $271,000
Q2 2022 Aug 12, 2022	SELL	$71.48 - $86.85 $268,050 - $325,687	-3,750 Closed	0 $0
Q1 2022 May 02, 2022	SELL	$74.28 - $92.69 $2,525 - $3,151	-34 Reduced 0.9%	3,750 $290,000
Q4 2021 Jan 28, 2022	SELL	$71.72 - $91.47 $15,850 - $20,214	-221 Reduced 5.52%	3,784 $335,000
Q3 2021 Nov 16, 2021	SELL	$74.77 - $85.47 $22,954 - $26,239	-307 Reduced 7.12%	4,005 $316,000
Q2 2021 Aug 10, 2021	BUY	$75.51 - $84.79 $23,559 - $26,454	312 Added 7.8%	4,312 $352,000
Q1 2021 May 13, 2021	BUY	$74.73 - $90.69 $52,759 - $64,027	706 Added 21.43%	4,000 $312,000
Q4 2020 Feb 04, 2021	SELL	$72.61 - $90.2 $8,132 - $10,102	-112 Reduced 3.29%	3,294 $290,000
Q3 2020 Nov 09, 2020	SELL	$71.87 - $131.03 $4,743 - $8,647	-66 Reduced 1.9%	3,406 $290,000
Q2 2020 Jul 31, 2020	SELL	$79.55 - $124.22 $155,520 - $242,850	-1,955 Reduced 36.02%	3,472 $429,000
Q1 2020 May 06, 2020	BUY	$71.37 - $96.85 $387,324 - $525,604	5,427 New	5,427 $460,000
Q3 2019 Nov 12, 2019	SELL	$67.4 - $85.11 $204,222 - $257,883	-3,030 Closed	0 $0
Q2 2019 Aug 05, 2019	BUY	$80.35 - $93.9 $243,460 - $284,517	3,030 New	3,030 $261,000

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on National Asset Management, Inc. with notifications on news.